SK Bioscience Archives | Be Korea-savvy
SK Bioscience Begins Supplying Novavax’s Updated COVID-19 Vaccine for XBB Subvariant

SK Bioscience Begins Supplying Novavax’s Updated COVID-19 Vaccine for XBB Subvariant

SEOUL, Dec. 12 (Korea Bizwire) — SK bioscience Co. said Tuesday it has started supplying Novavax’s updated COVID-19 vaccine to target the XBB.1.5 subvariant in South Korea. The vaccine, the only non-messenger RNA formulation against COVID-19 in the world, will be available for free at designated hospitals and health centers across the country starting next [...]

SK bioscience Inks Deal with Australian Firm to Develop Patch-type Typhoid Vaccine

SK bioscience Inks Deal with Australian Firm to Develop Patch-type Typhoid Vaccine

SEOUL, Aug. 24 (Korea Bizwire) — SK bioscience Co. said Thursday it has reached a deal with Vaxxas, an Australian biotechnology company, to jointly develop a new patch-type typhoid vaccine. The global charitable foundation Wellcome will fund the collaboration for the first two years, awarding US$3.67 million to conduct the first-phase clinical trial, according to [...]

SK bioscience to Provide 5 mln Doses of Cell-based Flu Vaccine SKYCellflu

SK bioscience to Provide 5 mln Doses of Cell-based Flu Vaccine SKYCellflu

SEOUL, Aug. 23 (Korea Bizwire) — SK bioscience Co., a pharmaceutical affiliate under South Korea’s SK Group, said Wednesday it will produce 5 million doses of its signature cell-based influenza vaccine SKYCellflu nationwide from next month for the coming winter season. It resumed the production two years after it had stopped manufacturing the prefilled syringe-typed [...]

SK bioscience to Help Thailand Set Up Infrastructure for Vaccine Manufacturing

SK bioscience to Help Thailand Set Up Infrastructure for Vaccine Manufacturing

SEOUL, July 5 (Korea Bizwire) — SK bioscience Co., a pharmaceutical affiliate of South Korea’s SK Group, said Wednesday it has joined hands with Thailand’s state-run drugmaker to build vaccine manufacturing and development infrastructure in the Southeast Asian country. SK bioscience and Thailand’s Government Pharmaceutical Organization (GPO) signed a memorandum of understanding (MOU) on Tuesday, [...]

SK Bioscience Inks Deal to Cooperate with CEPI on Developing mRNA Vaccines

SK Bioscience Inks Deal to Cooperate with CEPI on Developing mRNA Vaccines

SEOUL, Oct. 25 (Korea Bizwire) — South Korean drugmaker SK Bioscience Co. said Tuesday it has signed a deal to join hands with the Coalition for Epidemic Preparedness Innovations (CEPI) to develop messenger RNA (mRNA) vaccines. Under the agreement, SK Bioscience will receive US$140 million for the project from CEPI, an Oslo-based international public-private partnership, [...]

SK Bioscience’s SKYCovione Proven Effective Against Omicron Virus Subvariants as Booster Shot

SK Bioscience’s SKYCovione Proven Effective Against Omicron Virus Subvariants as Booster Shot

SEOUL, Sept. 2 (Korea Bizwire) — SKYCovione, South Korea’s first homegrown COVID-19 vaccine developed by SK Bioscience Co., has been proven to be effective against coronavirus omicron subvariants when administered as a booster shot, a state-run research center said Friday. The Center for Infectious Disease Research (CIDR) said it has confirmed through research SKYCovione’s efficacy [...]

S. Korea Approves Use of 1st Homegrown COVID-19 Vaccine from SK Bioscience

S. Korea Approves Use of 1st Homegrown COVID-19 Vaccine from SK Bioscience

SEOUL, June 29 (Korea Bizwire) — South Korea on Wednesday approved the use of SKYCovione, the country’s first homegrown COVID-19 vaccine developed by SK Bioscience Co., taking a major step toward achieving vaccine sovereignty in the fight against the pandemic. The Ministry of Food and Drug Safety (MFDS) said it approved the use of SKYCovione, [...]